Digital chronic care management tool Lark Health scooped up $55 million in its Series C round. In addition to the venture funding, the company added another $15 million through venture debt credit.
Kind River Capital led the round with participation from Franklin Templeton, SteelSky Ventures, Olive Tree Capital, Lightspeed Ventures, Asset Management Ventures and individual investors.
The...
Siren, a smart textile company known for its temperature-monitoring socks, has added another $9 million to an $11.8 million Series B raise from early summer. The latest raise adds new backers Manta Ray, Mighty Capital and David Helgason to the company's Series B round, which included names like Anathem Ventures, Khosla Ventures, DCM, Founders Fund and other prior investors.
WHAT IT DOES
Founded...
A new study jointly conducted by digital chronic care management tool Omada and Evidation Health found that patients using Omada’s diabetes management program reduced their A1c level and average of 0.8 over the course of the clinical research.
The study included a total of 195 participants with Type 2 diabetes who had an average baseline A1c of 8.93%. Researchers reported that those participants...
Following a study looking into how adults living with Type 2 diabetes use technology to self-monitor lifestyle and health behaviors, researchers from the University of Texas Health Science Center at San Antonio found that technology-assisted self-monitoring was safe and effective in generating positive health outcomes.
The researchers noted several limitations to the study, but say the findings...
Today One Drop announced a string of new deals with Bayer that could bring the digital diabetes-management company nearly $100 million in new funds.
The agreements include the closure of a Series C financing round led by the pharma giant, as well as $64 million in unspecified development commitments and potential commercial milestone payments.
Launched in late 2016, One Drop's wireless blood...
Picking through the scraps. Following the bankruptcy of 'digital pill' maker Proteus Digital Health, business partner and stakeholder Otsuka Pharmaceutical has been approved to purchase the digital health company's assets by a federal bankruptcy court judge, STAT reports.
Otsuka's bid was challenged by Novartis, two former Proteus executives and other investors, who argued that the agreed upon $...
Somerville, Massachusetts-based virtual diabetes care company Podimetrics has added yet another $8 million to its Series B-2 funding, bringing the round's closing total to $24.6 million, the startup told MobiHealthNews. Polaris Partners, Rock Health, Norwich Ventures and Scientific Health Development, all of which had previously backed the company, contributed.
Additionally, Podimetrics announced...
Continuous glucose monitoring (CGM) system-maker Senseonics has cut a deal with Ascensia Diabetes Care and its parent company, PHC Holdings, outlining commercialization and distribution of the Eversense product line over the next few years.
According to the companies, Ascensia now holds exclusive global distribution rights for the Eversense, Eversense XL and future CGMs. The duration of the...
Dexcom President and CEO Kevin Sayer is “incredibly proud” of what the company is calling “resilient growth” in the second quarter of 2020, according to an earnings call on Tuesday.
Despite having some uncertainty in the impacts of the COVID-19 pandemic, Dexcom was able to produce significant year-over-year growth in Q2 2020.
Sayer attributes much of the growth to a steady increase in knowledge...
A retrospective analysis of more than 2,000 Livongo Diabetes Prevention Program (DPP) participants found an average weight loss of 5.1% from baseline after 12 months, and 6.6% among those who designated as high engagers.
The study, conducted by Livongo and published in BMJ Open Diabetes Research & Care, honed in on the relationships between specific program behaviors and program engagement...
